Latest Interest Rates News

Universal Biosensors has signed a non-binding term sheet for an A$8.5 million senior secured loan with Viburnum Funds, alongside plans for an equity raising. The move comes with governance shifts, including a director resignation to avoid conflicts.

Butn Limited has locked in a $100 million senior secured debt facility with Northleaf Capital Partners, marking a pivotal step in its growth strategy and refinancing existing debt.

Latitude 66 Limited has agreed to sell its 17.5% stake in the Greater Duchess Copper Gold Joint Venture for an upfront $2 million, with potential for additional contingent payments. The deal includes a $750,000 loan to support ongoing projects in Finland and Western Australia.

Eildon Capital Group has revealed a significant loan repayment default by Kings Investment, alongside a cautious outlook for its FY25 financials amid a sluggish Melbourne property market.

Harvest Technology Group has raised $500,000 through unsecured convertible notes with a 15% annual interest rate, supporting its strategic three-year profit plan. The notes include attached options exercisable over two years, pending shareholder approval.

Norwood Systems has extended the repayment date on its key loan facility to July 31, 2025, with the principal reduced to $318,341 following significant repayments. This move supports the company’s ongoing growth initiatives, including its recent Optus contract win.

Rhythm Biosciences has obtained a $1 million non-dilutive loan backed by its FY2025 R&D Tax Incentive rebate, aiming to accelerate the commercial rollout of its ColoSTAT® test and expand its geneType™ platform.

Aeris Resources has completed the drawdown of a $60 million Guarantee Facility from Washington H. Soul Pattinson, alongside an extension of its Term Facility, freeing up restricted cash and reinforcing its financial flexibility.

ClearVue Technologies has secured $746,574 through a mix of equity and debt to support its international commercialisation efforts amid shifting market conditions.

Actinogen Medical has locked in up to $13.8 million in non-dilutive funding tied to its R&D tax incentives, bolstering its cash position as it advances a pivotal Alzheimer’s disease clinical trial.

Vinyl Group has secured a $1.5 million revolving credit facility from Songtradr and proposed converting historical liabilities into equity, aiming to boost its balance sheet and accelerate growth on its Vinyl.com platform.

Noble Helium has arranged a $200,000 unsecured loan from its Non-Executive Chair as a short-term refinancing measure, aiming to bolster working capital without diluting shareholders. The company plans a webinar to outline its refinancing and strategic direction.